Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Convertible Senior Notes Due 2022	Convertible Senior Notes Due 2026	Cumulative effect of adoption of ASU 2020-06, net of taxes	Common Stock	Common Stock Convertible Senior Notes Due 2022	Additional Paid-in Capital	Additional Paid-in Capital Convertible Senior Notes Due 2022	Additional Paid-in Capital Convertible Senior Notes Due 2026	Additional Paid-in Capital Cumulative effect of adoption of ASU 2020-06, net of taxes	Accumulated Deficit	Accumulated Deficit Cumulative effect of adoption of ASU 2020-06, net of taxes	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019	$ 220,312				$ 34		$ 425,945				$ (199,920)		$ (5,747)
Beginning Balance, shares at Dec. 31, 2019					33,848,627
Issuance of common stock in connection with acquisition	53,193						53,193
Issuance of common stock in connection with acquisition, shares					462,224
Stock-based compensation	47,079						47,079
Vesting of restricted stock units and performance-based restricted stock units, shares					451,879
Stock award shares withheld to settle employee tax withholding liability	(6,364)						(6,364)
Stock award shares withheld to settle employee tax withholding liability, shares					(48,469)
Exercise of stock options	8,160				$ 1		8,159
Exercise of stock options, shares					323,838
Issuance of shares under employee stock purchase plan	3,389						3,389
Issuance of shares under employee stock purchase plan, shares					49,319
Settlement of convertible notes due 2022		$ 11,375						$ 11,375
Settlement of convertible notes due 2022, shares						362,029
Other comprehensive income (loss)	8,557												8,557
Net loss	(93,396)										(93,396)
Balance at Dec. 31, 2020	252,305				$ 35		542,776				(293,316)		2,810
Ending Balance, shares at Dec. 31, 2020					35,449,447
Issuance of common stock in connection with acquisition	169,541						169,541
Issuance of common stock in connection with acquisition, shares					1,311,960
Issuance of common stock for contingent consideration	7,177						7,177
Issuance of common stock for contingent consideration, shares					51,914
Stock-based compensation	44,684						44,684
Vesting of restricted stock units and performance-based restricted stock units	2				$ 2
Vesting of restricted stock units and performance-based restricted stock units, shares					573,493
Stock award shares withheld to settle employee tax withholding liability	(10,085)						(10,085)
Stock award shares withheld to settle employee tax withholding liability, shares					(68,832)
Exercise of stock options	3,113						3,113
Exercise of stock options, shares					114,381
Issuance of shares under employee stock purchase plan	4,587						4,587
Issuance of shares under employee stock purchase plan, shares					41,164
Equity component of convertible notes due 2026, net of allocated issuance costs and taxes			$ 99,000						$ 99,000
Purchase of capped call hedge for the convertible notes due 2026, including issuance costs			$ (35,124)						$ (35,124)
Settlement of convertible notes due 2022		17,111				$ 2		17,109
Settlement of convertible notes due 2022, shares						1,916,206
Termination and modification of capped call hedge for convertible notes due 2022		$ 10,886						$ 10,886
Other comprehensive income (loss)	(5,712)												(5,712)
Net loss	(94,796)										(94,796)
Balance at Dec. 31, 2021	462,689			$ (137,979)	$ 39		853,664			$ (185,141)	(388,112)	$ 47,162	(2,902)
Ending Balance, shares at Dec. 31, 2021					39,389,733
Modification of 2022 Notes capped call options and resulting reclassification to derivative asset	6,110						6,110
Capped call termination and retirement of shares					(22,914)
Stock-based compensation	49,508						49,508
Vesting of restricted stock units and performance-based restricted stock units	1				$ 1
Vesting of restricted stock units and performance-based restricted stock units, shares					843,402
Stock award shares withheld to settle employee tax withholding liability	(6,307)						(6,307)
Stock award shares withheld to settle employee tax withholding liability, shares					(198,278)
Exercise of stock options	$ 144						144
Exercise of stock options, shares	9,883				9,883
Issuance of shares under employee stock purchase plan	$ 3,165						3,165
Issuance of shares under employee stock purchase plan, shares					105,696
Other comprehensive income (loss)	(27,046)												(27,046)
Net loss	(61,174)										(61,174)
Balance at Dec. 31, 2022	$ 289,111				$ 40		$ 721,143				$ (402,124)		$ (29,948)
Ending Balance, shares at Dec. 31, 2022					40,127,522